Welgus Howard G. — SEC Form 4 filings

SEC reporting owner CIK 1801050. 31 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2024-06-06 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arcutis Biotherapeutics, Inc. (ARQT)Director3133 legs · 255,412 sh · $4,373,16648

Form 4 filings — Welgus Howard G.

FiledFormIssuerReported transactionsSource
2026-09-174Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,019 @ $7.51 · Option exercise (M): 2,255 @ $8.63 · Sale (S): 4,730 @ $24.18 · Option exercise (M): 822 (derivative) @ $0 · Option exercise (M): 1,019 (derivative) @ $0 · +1 moreEDGAR
2026-08-194Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,019 @ $7.51 · Option exercise (M): 2,255 @ $8.63 · Sale (S): 4,730 @ $26.18 · Option exercise (M): 822 (derivative) @ $0 · Option exercise (M): 1,019 (derivative) @ $0 · +1 moreEDGAR
2026-07-174Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,019 @ $7.51 · Option exercise (M): 2,255 @ $8.63 · Sale (S): 4,730 @ $26.91 · Option exercise (M): 822 (derivative) @ $0 · Option exercise (M): 1,019 (derivative) @ $0 · +1 moreEDGAR
2026-06-174Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,019 @ $7.51 · Option exercise (M): 2,255 @ $8.63 · Sale (S): 4,096 @ $24.41 · Sale (S): 635 @ $25.67 · Option exercise (M): 822 (derivative) @ $0 · +2 moreEDGAR
2026-06-094Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 5,778 @ $0 · Grant/award (A): 16,667 (derivative) @ $0EDGAR
2026-05-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 7,144 @ $22.99EDGAR
2026-04-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $23.88EDGAR
2026-03-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $25.65EDGAR
2026-02-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $25.05EDGAR
2026-01-064Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $28.96EDGAR
2025-12-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $30.21EDGAR
2025-11-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $25.27EDGAR
2025-10-034Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 9,538 @ $1.68 · Sale (S): 9,538 @ $18.92 · Sale (S): 462 @ $18.92 · Option exercise (M): 9,538 (derivative) @ $0EDGAR
2025-09-044Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 10,000 @ $0 · Sale (S): 10,000 @ $15.64 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2025-08-054Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 6,110 @ $0 · Sale (S): 6,110 @ $14.30 · Option exercise (M): 3,890 @ $0 · Sale (S): 3,890 @ $14.30 · Option exercise (M): 6,110 (derivative) @ $0 · Option exercise (M): 3,890 (derivative) @ $0EDGAR
2025-07-024Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 9,208 @ $13.84EDGAR
2025-06-204Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,139 @ $13.37EDGAR
2025-06-164Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 7,609 @ $0 · Grant/award (A): 20,568 (derivative) @ $0EDGAR
2025-05-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $14.64EDGAR
2025-04-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $15.12EDGAR
2025-03-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $13.00EDGAR
2025-02-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $12.71EDGAR
2025-01-064Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $14.67EDGAR
2024-12-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $12.51EDGAR
2024-11-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $8.65EDGAR
2024-10-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $9.26EDGAR
2024-09-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 10,000 @ $10.77EDGAR
2024-08-054Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 6,614 @ $1.68 · Sale (S): 6,614 @ $9.87 · Sale (S): 3,386 @ $9.87 · Option exercise (M): 6,614 (derivative) @ $0EDGAR
2024-07-024Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 5,681 @ $1.68 · Option exercise (M): 4,319 @ $1.68 · Sale (S): 10,000 @ $9.31 · Option exercise (M): 5,681 (derivative) @ $0 · Option exercise (M): 4,319 (derivative) @ $0EDGAR
2024-06-184Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 10,139 @ $0 · Grant/award (A): 27,052 (derivative) @ $0EDGAR
2024-06-064Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 3,542 @ $1.68 · Option exercise (M): 6,458 @ $1.68 · Sale (S): 3,542 @ $8 · Sale (S): 6,458 @ $8.01 · Option exercise (M): 3,542 (derivative) @ $0 · Option exercise (M): 6,458 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1801050 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →